Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291637 · ClinicalTrials.gov registry record
Posterior cerebraL ArTery Occlusion Study
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 1,282
- Enrollment target
NCT05291637: Completed study, sponsored by Boston Medical Center.
NCT05291637 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 1,282 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05291637 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 1,282 participants
- Enrollment target
Study Summary
For this retrospective study, the investigators will collect and analyze data of patients who presented with posterior artery occlusion and underwent mechanical thrombectomy (the type of endovascular stroke treatment) and intravenous thrombolysis (the type of non-endovascular stroke treatment). The electronic health records will be queried for the demographic, medical history, and outcomes data of all patients with posterior cerebral artery occlusion who underwent mechanical thrombectomy, intravenous thrombolysis (IVT), or medical management.
Primary Outcome
The Modified Rankin Scale (mRS) assesses disability in patients who have suffered a stroke and is compared over time to check for recovery and degree of continued disability. Scores can range from 0-6, where 0 is no disability, 5 is disability requiring constant care for all needs, and 6 is death. For this outcome an ordinal shift analysis will be done, assessing all changes across the range from baseline at 90 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,282 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2023-01-31 |
What the finished NCT05291637 record still lists
NCT05291637 is an observational study that tracks outcomes without assigning an intervention. Its 1,282 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05291637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05291637 about?
NCT05291637 is a clinical study titled "Posterior cerebraL ArTery Occlusion Study". For this retrospective study, the investigators will collect and analyze data of patients who presented with posterior artery occlusion and underwent mechanical thrombectomy (the type of endovascular stroke treatment) and intravenous thrombolysis (the type of non-endovascular stroke treatment). The...
What is the current status of trial NCT05291637?
This trial is currently completed. The enrollment target is 1,282 participants. The study started on 2022-01-05. Estimated completion is 2023-01-31.
Who is sponsoring clinical trial NCT05291637?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI